12-year-old Oran Knowlson, a Somerset epilepsy patient, becomes the first to trial a new neurostimulator device, reducing his daytime seizures by 80%.
12-year-old Oran Knowlson from Somerset has become the first patient in the world to trial a new epilepsy device fitted in his skull. The neurostimulator, made by UK company Amber Therapeutics, aims to block or disrupt abnormal brain signals that trigger seizures. The device has reduced Oran's daytime seizures by 80%, improving his quality of life and allowing him to engage more fully with his family.
June 23, 2024
3 Articles